Veterinary Medicines

Zerofen 100 mg/ml Oral Suspension

Authorised
  • Fenbendazole
Download as PDF

Product identification

Medicine name:
Zerofen 100 mg/ml Oral Suspension
Active substance:
  • Fenbendazole
Target species:
  • Cattle
Route of administration:
  • Oral use

Product details

Active substance and strength:
  • Fenbendazole
    10.00
    gram(s)
    /
    100.00
    millilitre(s)
Pharmaceutical form:
  • Oral suspension
Withdrawal period by route of administration:
  • Oral use
    • Cattle
      • Meat and offal
        14
        day
      • Milk
        96
        hour
Anatomical therapeutic chemical veterinary (ATCvet) codes:
  • QP52AC13
Legal status of supply:
  • Veterinary medicinal product subject to veterinary prescription
Authorisation status:
  • Valid
Authorised in:
  • Ireland
Package description:
  • The product is presented in 10 L containers composed of high density polyethylene with highdensity polyethylene closures.
  • The product is presented in 5 L containers composed of high density polyethylene with highdensity polyethylene closures.
  • The product is presented in 2.5 L containers composed of high density polyethylene with highdensity polyethylene closures.
  • The product is presented in 1 L containers composed of high density polyethylene with highdensity polyethylene closures.
  • The product is presented in 0.5 L containers composed of high density polyethylene with highdensity polyethylene closures.

Additional information

Entitlement type:
  • Marketing Authorisation
Legal basis of product authorisation:
  • Informed consent (abridged application) - Council Directive 81/851/EEC
Marketing authorisation holder:
  • Chanelle Pharmaceuticals Manufacturing Limited
Marketing authorisation date:
Manufacturing sites for batch release:
  • Chanelle Pharmaceuticals Manufacturing Limited
Responsible authority:
  • Health Products Regulatory Authority
Authorisation number:
  • VPA10987/017/001
Date of authorisation status change:

Documents

Summary of Product Characteristics

English (PDF)
Published on: 25/09/2024
Download